Does uric acid have a pathogenetic role in graft dysfunction and hypertension in renal transplant recipients?

Uric acid (UA) may play a pathogenetic role in hypertension and kidney disease. We explored the prevalence of hyperuricemia and the relationship of UA to graft function and hypertension in prevalent renal transplant recipients (RTR).
Baseline and follow-up data were collected on 90 RTR (mean age 51 yrs, 53% male, median transplant duration 7 years). Graft function was estimated using MDRD Study Equation 7.
At baseline, 70% RTR had hyperuricemia (UA >7.0 mg/dl (0.42 mmol/L) in men and >6.0 mg/dl (0.36 mmol/L) in women) compared to 80% after 2.2 years (P=0.06). UA was not associated with blood pressure (BP) level but was higher in RTR with a history of hypertension compared to those without (8.6+/-1.8 vs. 7.3+/-2.2 mg/dl, [0.51+/-0.11 vs. 0.43+/-0.13 mmol/L], P=0.003) and in RTR on > or =3 antihypertensive medications compared to those taking less (9.1+/-1.6 vs. 7.6+/-1.8 mg/dL, [0.54+/-0.1 vs. 0.45+/-0.11 mmol/L], P<0.001). A history of hypertension was independently predictive of UA (beta 0.06, [95% CI 0.02 to 0.10], P=0.007) in addition to sex, cyclosporine dose, prednisolone dose, estimated glomerular filtration rate (eGFRMDRD) and beta-blocker therapy. UA was independently predictive of follow-up eGFRMDRD (beta -22.2 [95% CI -41.2 to -3.2], P=0.02) but did not predict change in eGFRMDRD over time. UA was independently associated with requirement for antihypertensive therapy (beta 0.34, [95% CI 1.05 to 1.90], P=0.02).
Hyperuricemia is common in RTR and is associated with need for antihypertensive therapy and level of graft function.
AuthorsKirsten A Armstrong, David W Johnson, Scott B Campbell, Nicole M Isbel, Carmel M Hawley
JournalTransplantation (Transplantation) Vol. 80 Issue 11 Pg. 1565-71 (Dec 15 2005) ISSN: 0041-1337 [Print] United States
PMID16371927 (Publication Type: Journal Article)
Chemical References
  • Antihypertensive Agents
  • Biomarkers
  • Diuretics
  • Immunosuppressive Agents
  • Uric Acid
  • Adult
  • Antihypertensive Agents (therapeutic use)
  • Biomarkers (blood)
  • Body Mass Index
  • Cohort Studies
  • Diuretics (therapeutic use)
  • Female
  • Follow-Up Studies
  • Glomerular Filtration Rate
  • Humans
  • Hypertension (drug therapy, epidemiology)
  • Immunosuppressive Agents (therapeutic use)
  • Kidney Transplantation (pathology, physiology)
  • Male
  • Middle Aged
  • Postoperative Complications (epidemiology)
  • Predictive Value of Tests
  • Retrospective Studies
  • Uric Acid (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: